SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Pathways (CLPA)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bob who wrote (48)11/24/1998 9:34:00 AM
From: Mike J  Read Replies (1) of 566
 
Great comments. I suppose we'll see what kind of faith the officers have in this company (and Prevatac) at the end of April when their 180 days are up...

One thing I don't get, though, is the quote by the NY hedge fund manager: "You could take the new COX-2. Probably if they modify those, it'll work for the disease, too." Is "they" CLPA? What does he refer to when he says "those"? "It'll" refers to COX-2 or Prevatac? Horrible quote.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext